|1.||Vlodavsky, Israel: 13 articles (06/2015 - 11/2002)|
|2.||Sanderson, Ralph D: 13 articles (01/2015 - 07/2002)|
|3.||Friedl, Andreas: 10 articles (11/2013 - 01/2002)|
|4.||Li, Jin-Ping: 8 articles (06/2015 - 05/2007)|
|5.||Esko, Jeffrey D: 8 articles (03/2015 - 01/2002)|
|6.||Oh, Eok-Soo: 8 articles (02/2015 - 11/2005)|
|7.||van Kuppevelt, Toin H: 8 articles (11/2013 - 03/2004)|
|8.||Qiao, Dianhua: 7 articles (11/2013 - 05/2003)|
|9.||Yang, Yang: 7 articles (09/2009 - 12/2003)|
|10.||Meyer, Kristy: 6 articles (11/2013 - 01/2002)|
02/01/2014 - "Potential roles of vessel wall heparan sulfate proteoglycans in atherosclerosis."
03/01/1997 - "Glucosamine may retard atherogenesis by promoting endothelial production of heparan sulfate proteoglycans."
01/01/1991 - "Higher aortic HSPG and DSCSPG (but lower DS) in samples from Nanning than those from Beijing might be implicated in the lower prevalence of atherosclerosis in the former."
04/25/2003 - "CSPG-DSPG has auxo-action on atherogenesis in graft, but HSPG protects the graft against atherogenesis to an extent."
03/01/1997 - "It is reasonable to speculate that exogenous glucosamine will likewise enhance heparan sulfate proteoglycans production by vascular endothelial cells, and, when administered orally in regimens comparable to those effective in osteoarthritis, will thereby act to retard atherogenesis."
10/01/2009 - "Replacement of adenovirus type 5 fiber shaft heparan sulfate proteoglycan-binding domain with RGD for improved tumor infectivity and targeting."
03/01/2012 - "In this study, we demonstrated that the extracellular sulfatase, SULF2, an enzyme that regulates multiple HSPG-dependent RTK signaling pathways, was expressed in primary human GBM tumors and cell lines. "
06/26/2007 - "In this study, we demonstrate that cell surface heparan sulfate proteoglycans (HSPGs), expressed by target cells, are involved in the recognition of tumor cells by NKp44. "
09/01/1990 - "This study compared HSPG and CSPG in adhesion sites of isogenic metastatic lung tumor cells (v-Ki-ras-transformed 3T3 cells) after injection by different routes (IV and footpad) into athymic nude mice. "
11/01/2014 - "Here, Chung and colleagues show that dendritic cell-associated, heparan sulfate proteoglycans-dependent integrin ligand (DC-HIL), a cell surface immune-modulatory molecule, is highly expressed on tumor-associated MDSCs. "
12/01/2006 - "Capsid modifications overcome low heterogeneous expression of heparan sulfate proteoglycan that limits AAV2-mediated gene transfer and therapeutic efficacy in human ovarian carcinoma."
12/01/2009 - "In this study, we analyzed APRIL and HSPG expression in the colon carcinoma cell line, SW480 by Western blot and RT-PCR. "
01/01/1995 - "The purpose of this study was to determine if human prostate carcinoma cells (PC-3) synthesized HSPG in tissue culture. "
01/01/2015 - "Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells."
03/20/2005 - "Profiling heparan sulfate proteoglycans in ovarian carcinoma."
09/01/2013 - "Collectively, these studies demonstrate that the level of HSPG 6-O sulfation is a critical determinant of C. muridarum infection in vivo and that 6-O endosulfatases are previously unappreciated modulators of microbial pathogenesis. "
01/01/2006 - "Studies in mutant Chinese Hamster Ovary cell lines known to be completely deficient in surface HSPG also demonstrated only moderate effect of absence of HSPG on rAAV-2 infection efficacy. "
07/01/2015 - "Required for infection, the cleavage was facilitated by prior interaction of viral particles with heparan sulfate proteoglycans. "
01/01/2015 - "Because negatively charged, cell-surface heparan sulfate proteoglycans (HSPGs), serve as the attachment receptor during the adsorption phase of the CMV infection cycle, we hypothesized that p5+14 effectively competes for CMV adsorption to the cell surface resulting in the reduction in infection. "
12/01/2014 - "Following pre-treatment of C7-10 cells with bLF, plaques from tissue culture-adapted high-titer SINVTaV-GFP-TC were observed at 48 h post-infection (p.i.), while plaques from low-titer SINVTaV-GFP-TC were not observed until 120 h p.i. Confocal optics detected this reporter virus at 30 days p.i. in the SG proximal lateral lobe, a region of HSPG-immunolocalization. "
10/01/1989 - "Authors studied the dispersion of immunoreactive HSPG with monoclonal antibody specific to protein nucleus of HSPG in renal diseases associated with nephrosis syndrome. "
04/01/1984 - "These results indicate that there are no significant alterations in the anionic sites rich in heparan sulfate proteoglycan during the entire course of PAN nephrosis."
01/01/2001 - "In control rats, Adriamycin nephrosis was associated with significantly impaired GBM staining for both HSPG core protein (assessed from BL-31 staining) and HS staining (assessed from JM-403 staining) 12 weeks after disease induction. "
09/01/1996 - "Since HSPG is one of the charge proteins of the basement membrane, the little changes observed for HSPG are difficult to interpret in view of reported decreases in basement membrane anionic sites in nephrosis. "
05/01/1991 - "These results indicate that the expression of basement membrane genes for alpha 1 (IV), laminin, and HSPG was abnormally regulated in PAN nephrosis and that this abnormal gene regulation might contribute to the development of proteinuria."
|1.||Messenger RNA (mRNA)
|5.||Apolipoproteins E (ApoE)
|6.||Conditioned Culture Media
|2.||Homologous Transplantation (Allograft)
|3.||Angioplasty (Angioplasty, Transluminal)
|5.||Heterologous Transplantation (Xenotransplantation)